pacb.com (PACB) - הכנסות החברה
Pacific Biosciences (PACB) relies on its unique HiFi sequencing method, aiming to optimize the cost of assays. System production is based in high-tech US R&D centers with strict purity controls. Complex patents and software costs ensure a high barrier to entry. The company's revenue chart reflects cash flow dynamics, with the indicator holding at 0.16.
פילוחי מדדים מקיפים ואנליטיקה עבור PacBio Corp (PACB)
Pacific Biosciences (PACB) sales reflect the aggregate cash flow from the sale of goods and services over a specific period. This indicator measures market demand and the business's operational efficiency. By analyzing the volatility of the company's sales, an investor assesses the business's resilience to macroeconomic pressure. For Pacific Biosciences (PACB), this metric is driven by the sale of DNA sequencing systems and associated consumables. Revenue stability confirms the demand for genetic technologies.
